
Mild/moderate relapsing MS patients
A disease modifying therapy that has over 20 years of experience and over 1.45 million patients years use1

can be found here

Highly active relapsing MS patients
An innovatively simple approach for adults with highly active relapsing MS2

can be found here

Meetings & Events
Merck is committed to supporting your professional development. We are proud to provide opportunities for Healthcare Professionals to share best practice through a range of peer-to-peer educational workshops and interactive seminars about the changing MS landscape and Merck products.



About MeRCk
Merck KGaA: A leader in Healthcare, Life Science and Performance Materials. Merck is a leading science and technology company specialising in healthcare, life science and performance materials.
Our healthcare expertise extends through specialist therapeutic areas including neurology, oncology, fertility and general medicine.

Downloadable Resources
As the biopharma business of Merck, we have an enduring commitment to transform lives through innovative medicines and high-value solutions.
Merck is at the forefront of cutting edge MS research and we link relevant clinical and non-clinical publications for you here.

Subscribe
Subscribe to our Merck Neurology emails to keep up-to-date with any new content from the Merck Neurology team including our peer-to-peer speaker meetings, patient awareness campaigns and other resources to support you in your clinical practice.
- Merck. Data on file (UKDOFREB160002)
- MAVENCLAD® Summary of Product Characteristics. Merck